The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system
about
Wnt signalling in lung development and diseasesGenetically manipulated mouse models of lung disease: potential and pitfallsFunctions of type II pneumocyte-derived vascular endothelial growth factor in alveolar structure, acute inflammation, and vascular permeability.miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.Gender affects skin wound healing in plasminogen deficient mice.Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.Pivotal role of cathepsin K in lung fibrosis.Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regenerationUrokinase and its receptors in chronic kidney disease.Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.NRF2 deficiency reduces life span of mice administered thoracic irradiation.Plasminogen activator/plasmin system: a major player in wound healing?The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.Lipidomics revealed idiopathic pulmonary fibrosis-induced hepatic lipid disorders corrected with treatment of baicalin in a murine model.Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in miceIncreased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel culturesImpact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblastsReduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1.A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.Plasminogen is an important regulator in the pathogenesis of a murine model of asthmaMacrophage elastase (MMP-12): a pro-inflammatory mediator?Epithelial-mesenchymal interactions in pulmonary fibrosis.The intrinsic pathway of coagulation: a target for treating thromboembolic disease?A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.PAI-1 and kidney fibrosis.Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosisAdvances in mechanisms of repair and remodelling in acute lung injury.Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.Genes involved in innate immunity associated with asbestos-related fibrotic changesPlasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.PAI-1 in tissue fibrosis.The inflammatory actions of coagulant and fibrinolytic proteases in disease.
P2860
Q25256712-99A1CBAA-6631-410B-B8D2-67B2CB367B98Q28388821-9783FABE-93D3-4423-AFC3-91BC34B7F8ECQ33745160-68F51C21-6C7C-4236-86DD-3E3F0376A894Q34607960-CFC9D35E-435F-459D-970C-53C38EC35498Q34626531-7A4A3937-1CD5-4B11-ACF8-A4EBD36DEE2FQ34635604-ADE525CA-C27D-41FB-901F-B61909F2ACC5Q35085377-0EF43E35-2125-4C21-9FB9-517019DEB738Q35088199-34A20424-ECB6-4C96-897A-71D8A5A9A4D5Q35096108-B088C6ED-2103-4045-8B04-C519AC6711A0Q35098381-082410FA-1F58-4A6E-A2A2-18EA849CB144Q35118672-3E011FE6-E8AB-4B3E-80B8-393B07CF3A32Q35124141-B1250FCD-F0AF-4A02-8F86-CBEA360987CBQ35130515-D5D1BC2C-14AB-4C6C-B271-7A52460C15C6Q35165109-55181CD2-8E0F-431C-B143-A65E64B17552Q35170968-9AF28612-FF5B-4F62-BB91-150D170FC5BBQ35182731-2DE9F1FB-E2E1-4151-8F8B-1DD609672929Q35221823-10BAD74A-04C7-449A-B7E7-A12D965DE136Q35529156-387DB024-4160-4485-BCFB-48195449683FQ35676548-ACF7ABF6-141B-4883-9995-5E1842A43C24Q35749077-EE57EE70-B27F-4E75-90BC-FC566941424AQ35749147-A52CE92E-5FEC-4E34-88D9-7B6B23466D4BQ35791725-93A85E73-3755-43E1-8071-47B238E880B7Q35829481-51F88524-FB38-4CDF-A628-2244ABB0ADE2Q35950247-89EB6B92-77DC-4F60-BE9E-A96A069BC3C2Q36013653-597964E6-9FC7-486F-8F8A-3163F6FFFA65Q36165913-3BA479A2-C1E4-4A7B-BEBF-4D686C0B3957Q36427136-63D75504-8E00-4FA6-9D54-B290585431EBQ36771762-0BC229C7-CE96-4CDA-A218-E6D84207E758Q36777944-1836E8DB-3F9A-4F4C-AFC0-9EFE3BE48D52Q36846526-E353C224-E587-40AB-AAF1-35719EAD0A6EQ36940906-1F3F1CDC-5772-47FE-86C3-71EDBFC6123FQ37081002-AEB8A92C-306C-4D64-A305-AF1EF90A2448Q37264711-765E577D-824C-495D-B9CC-E55856C3F365Q37271801-14140AD5-1789-4188-9818-CF778429186AQ37286882-CF04F7D9-ABAA-479B-A336-3367A4A64E97Q37460349-10FE00D9-7392-47A7-A175-00CBC6DCF649Q37465454-EB9F0B56-72EB-4F71-B6A6-4A474A5EEE2DQ37596163-136A5C8D-3C27-47A7-B9DC-61106346FA13Q37861626-EB6B914D-636A-4D6D-818D-5F864DE0AD9BQ38423064-E832070A-04B5-4273-BF67-866D6E4E227D
P2860
The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The development of bleomycin-i ...... nts of the fibrinolytic system
@ast
The development of bleomycin-i ...... nts of the fibrinolytic system
@en
type
label
The development of bleomycin-i ...... nts of the fibrinolytic system
@ast
The development of bleomycin-i ...... nts of the fibrinolytic system
@en
prefLabel
The development of bleomycin-i ...... nts of the fibrinolytic system
@ast
The development of bleomycin-i ...... nts of the fibrinolytic system
@en
P2093
P2860
P1476
The development of bleomycin-i ...... nts of the fibrinolytic system
@en
P2093
C M Swaisgood
E L French
V A Ploplis
P2860
P304
P356
10.1016/S0002-9440(10)64529-4
P407
P577
2000-07-01T00:00:00Z